As first observed in melanoma, some tumour cells can overexpress PD-L1, increasing the interaction between PD-L1 and PD-1 and thus inactivating T lymphocytes that attempt to trigger an immune response against the tumour (Figure 1C). The gene discussed is CD274; the disease is neoplasm.